Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|March 22, 2020
Loss of ISWI ATPase SMARCA5 (SNF2H) in Acute Myeloid Leukemia Cells Inhibits Proliferation and Chromatid CohesionTomas Zikmund, Helena Paszekova, Juraj Kokavec, et al.
The EMBO Journal|September 8, 2011
Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiationVit Pospisil, Karin Vargova, Juraj Kokavec, et al.
Biochimica Et Biophysica Acta|October 4, 2016
Distinct and overlapping DNMT1 interactions with multiple transcription factors in erythroid cells: Evidence for co-repressor functionsDimitris N Papageorgiou, Elena Karkoulia, Alexandra Amaral-Psarris, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Chromatin remodeling enzyme Snf2h is essential for retinal cell proliferation and photoreceptor maintenanceAndrea Kuzelova, Naoko Dupacova, Barbora Antosova, et al.
Cells|April 13, 2023
Chromatin Remodeling Enzyme Snf2h Is Essential for Retinal Cell Proliferation and Photoreceptor MaintenanceAndrea Kuzelova, Naoko Dupacova, Barbora Antosova, et al.
Immunity|September 26, 2025
Control of myeloid lineage fidelity and response to stimuli by ISWI-enforced nucleosome phasingSara Polletti, Júlia Melià-Alomà, Francesco Pileri, et al.
Acta Ophthalmologica|May 3, 2019
Paraproteinemic keratopathy associated with monoclonal gammopathy of undetermined significance (MGUS): clinical findings in twelve patients including recurrence after keratoplastyPavlina Skalicka, Lubica Dudakova, Michalis Palos, et al.
Communications Biology|February 29, 2024
Differential requirements for Smarca5 expression during hematopoietic stem cell commitmentTereza Turkova, Juraj Kokavec, Tomas Zikmund, et al.
Cancers|May 14, 2022
Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL LymphomasPavle Krsmanovic, Heidi Mocikova, Kamila Chramostova, et al.
Leukemia Research|April 4, 2018
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients)Anna Jonasova, Radana Neuwirtova, Helena Polackova, et al.
Pageof 4